Hippocampal subfield volumes in short- and long-term lithium-treated patients with bipolar I disorder

Bipolar Disorders

Volumn 18, Issue 4, 2016, Pages 352-362

  Simonetti, Alessio ^a,b,c   Sani, Gabriele ^a,b,c   Dacquino, Claudia ^b   Piras, Fabrizio ^b,d   De Rossi, Pietro ^a,b,c   Caltagirone, Carlo ^b,e   Coryell, William ^f   Spalletta, Gianfranco ^b,g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Santa Lucia Foundation   (Italy)

^c Centro Lucio Bini   (Italy)

^d Centro Studi e Ricerca Enrico Fermi   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF IOWA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

bipolar disorder; hippocampal subfields; hippocampus; lithium; treatment

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM SALT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR I DISORDER; BRAIN SIZE; CONTROLLED STUDY; DENTATE GYRUS; DENTATE HILUS; DRUG EFFECT; FEMALE; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; LEFT HEMISPHERE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL; RIGHT HEMISPHERE; SHORT COURSE THERAPY; SUBICULUM;

EID: 84976645950     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12394     Document Type: Article

References (53)

1. Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML. Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord 2012; 14: 375–410.
2. Haukvik UK, Westlye LT, Mørch-Johnsen L et al. In Vivo Hippocampal subfield volumes in schizophrenia and bipolar disorder. Biol Psychiatry 2015; 77: 581–588.
3. Bertolino A, Frye M, Callicott JH et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003; 53: 906–913.
4. Konradi C, Zimmerman EI, Yang CK et al. Hippocampal Interneurons in Bipolar Disorder 2011; 68: 340–350.
5. Mathew I, Gardin TM, Tandon N et al. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. JAMA Psychiatry 2014; 71: 769–777.
6. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000; 75: 1729–1734.
7. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS. Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci USA 2004; 101: 3973–3978.
8. Hajek T, Kopecek M, Höschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci 2012; 37: 333–343.
9. Yucel K, Taylor VH, McKinnon MC et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 2008; 33: 361–367.
10. Monkul ES, Matsuo K, Nicoletti MA et al. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett 2007; 429:7–11.
11. Van Leemput K, Bakkour A, Benner T et al. Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 2009; 19: 549–557.
12. Bearden CE, Thompson PM, Dutton RA et al. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology 2008; 33:1229–1238.
13. Giakoumatos CI, Nanda P, Mathew IT et al. Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder. J Psychiatr Res 2015; 61: 180–187.
14. Hartberg CB, Jørgensen KN, Haukvik UK et al. Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder. Bipolar Disord 2015; 17: 496–506.
15. Van Erp TGM, Thompson PM, Kieseppä T et al. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Hum Brain Mapp 2012; 33: 501–510.
16. Yucel K, McKinnon MC, Taylor VH et al. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology 2007; 195: 357–367.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press, Inc., 2000.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
19. First MB, Gibbon M, Spitzer RL. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: Am Psychiatr Press Inc, 1997.
20. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
21. Measso G, Cavarzeran F, Zappalà G et al. The mini-mental state examination: normative study of an Italian random sample. Developmental Neuropsychology 1993; 2: 77–85.
22. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996; 36: 378–384.
23. Iorio M, Spalletta G, Chiapponi C et al. White matter hyperintensities segmentation: a new semi-automated method. Front Aging Neurosci 2013; 5: 76.
24. Hajek T, Cullis J, Novak T et al. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord 2012; 14: 261–270.
25. Hajek T, Bauer M, Simhandl C et al. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med 2014; 44: 1–11.
26. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl. 2003; 108: 1–22.
27. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
28. Deichmann R, Schwarzbauer C, Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. NeuroImage 2004; 21: 757–767.
29. Ségonne F, Dale AM, Busa E et al. A hybrid approach to the skull stripping problem in MRI. NeuroImage 2004; 22: 1060–1075.
30. Fischl B, Salat DH, Busa E et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341–355.
31. Fischl B, Salat DH, Van Der Kouwe AJW et al. Sequence-independent segmentation of magnetic resonance images. NeuroImage 2004; 23 (Suppl. 1): S69–S84.
32. Buckner RL, Head D, Parker J et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage 2004; 23: 724–738.
33. Sanfilipo MP, Benedict RHB, Zivadinov R, Bakshi R. Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method. NeuroImage 2004; 22: 1732–1743.
34. Gaddis ML. Statistical methodology: IV. Analysis of variance, analysis of covariance, and multivariate analysis of variance. Acad Emerg Med 1998; 5: 258–265.
35. Mander AJ. Use of lithium and early relapse in manic-depressive illness. Acta Psychiatr Scand 1988; 78: 198–200.
36. Sani G, Tondo L, Koukopoulos A et al. Suicide in a large population of former psychiatric inpatients. Psychiatry Clin Neurosci 2011; 65: 286–295.
37. Posener JA, Wang L, Price JL et al. High-dimensional mapping of the hippocampus in depression. Am J Psychiatry 2003; 160: 83–89.
38. Otten M, Meeter M. Hippocampal structure and function in individuals with bipolar disorder : a systematic review. J Affect Disord 2015; 174: 113–125.
39. Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry 2010; 167: 1178–1193.
40. Malykhin NV, Carter R, Seres P, Coupland NJ. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci 2010; 35: 337–343.
41. Stan TL, Alvarsson A, Branzell N, Sousa VC, Svenningsson P. NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum. Transl Psychiatry Nature Publishing Group 2014; 4: e395.
42. Ming GL, Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011; 70: 687–702.
43. Boku S, Nakagawa S, Masuda T et al. Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3beta and beta-catenin/TCF pathway. Neuropsychopharmacology 2009; 34: 805–815.
44. Manji HK, Etcheberrigaray R, Chen G, Olds JL. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme. J Neurochem 1993; 61: 2303–2310.
45. Calabrese B, Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005; 48: 77–90.
46. Dixon JF, Hokin LE. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA 1998; 95: 8363–8368.
47. Malhi G, Tanious M, Das P, Coulston C, Berk M. Potential mechanisms of action of lithium in bipolar disorder : current understanding. CNS Drugs 2013; 27: 135–153.
48. Regenold WT. Lithium and increased hippocampal volume-more tissue or more water? Neuropsychopharmacology 2008; 33: 1773–1774.
49. Gerhard T, Devanand DP, Huang C, Crystal S, Olfson M. Lithium treatment and risk for dementia in adults with bipolar disorder : population-based cohort study. Br J Psychiatry 2015; 207: 46–51.
50. Centorrino F, Fogarty KV, Sani G, Salvatore P, Cimbolli P, Baldessarini RJ. Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol 2005; 20: 355–358.
51. Post RM, Ketter TA, Pazzaglia PJ et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Suppl 1996; 11: 153–180.
52. Musenga A, Saracino MA, Sani G, Raggi MA. Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring. Curr Med Chem 2009; 16: 1463–1481.
53. Phatak P, Shaldivin A, King LS, Shapiro P,Regenold WT. Lithium and inositol: Effects on brain water homeostasis in the rat. Psychopharmacology 2006; 186: 41–47.